Nutrien Ltd. (NTR), the Saskatoon, Canada-based crop-input producer operating across Potash, Nitrogen, Phosphate, and Retail segments, carries a "Buy" consensus but with unusually wide dispersion. The overall average of roughly 26 targets is near $77, with a low around $62 and a high near $90.
Because that overall average sits less than 10% above the latest price, the $81 central target is instead the average of only the verified targets above the current price. Recent above-price targets include RBC Capital at $85, CIBC at $85, TD Cowen at $83, BMO Capital at $82, Bank of America Securities at $80, J.P. Morgan at $80, BNP Paribas at $80, Oppenheimer at $78, Barclays at $78, and Morgan Stanley at $76.
The spread reflects genuine disagreement. Bullish analysts emphasize tightening global potash supply and improving nitrogen economics, while cautious voices — including at least one Sell-rated view — flag that fertilizer pricing remains well below 2022 peaks and that retail volumes depend on farm income and weather. Several firms raised targets during 2026 before trimming them as commodity prices pulled back, a pattern worth watching.
With the stock near $71.24, reaching $81 requires about a 14% advance. Nutrien trades at roughly 14–15 times forward earnings and offers a forward dividend of $2.20 per share, a yield near 3%, while the 52-week range spans $54.52 to $85.36. Trailing EPS (earnings per share) stands near $4.58.
A move toward $81 would likely depend less on valuation re-rating and more on confirmation that potash and nitrogen prices are stabilizing at higher levels and that 2027 earnings estimates — currently in the low $5 range per share — are achievable. The stock has already recovered substantially from its 52-week low, so incremental gains may require fresh earnings evidence rather than sentiment alone.
The 52-week high near $85.36 stands out as the most meaningful overhead reference point, effectively capping the $81 target. The stock's recovery from the $54.52 low has been steady, and the $68–$70 zone has acted as support during recent pullbacks. A sustained move through the mid-$70s toward $81 would bring the $85 resistance level into focus, a psychologically important area where prior rallies stalled.
Analyst price targets generally reflect a roughly 12-month horizon, though individual firms apply different methodologies. Key items to watch include quarterly earnings (the next fiscal-year report is expected in February 2027), guidance on potash and nitrogen volumes, and any analyst target revisions. Broader inputs such as global grain prices, energy costs, interest rates, and currency moves in the Canadian dollar also matter for this globally diversified producer.
AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Traders can use these signals to discover opportunities, monitor existing positions, and spot shifting trends more efficiently than manual screening allows. For investors tracking a cyclical name like Nutrien, automated signals can help flag momentum changes as commodity markets evolve.
Can Nutrien reach $81? The target, representing the average of analyst price targets above the current price, sits about 14% above the latest quote — a plausible but not guaranteed move. Support comes from recovering fertilizer fundamentals, an attractive dividend, and reasonable valuation, while the principal obstacles are commodity-price volatility and an unusually wide analyst range from roughly $62 to $90. The overall mean of all targets near $77 underscores that the higher $81 figure reflects only the more constructive views. Investors should monitor fertilizer pricing, upcoming earnings guidance, and analyst revisions rather than treat any single number as a certainty.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, NTR has been closely correlated with CF. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTR jumps, then CF could also see price increases.